Company: ZCARW
Filing Date: 2025-05-12
Form Type: S-1/A
Source: 0001213900-25-041769
Chunk: 99

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-05-12
Form: S-1/A
Chunk 99
---
 file the registration statement and have such registration statement declared effective) and accrue and are thereafter payable on each monthly anniversary of such Event Date until such event has been cured. Accordingly, we believe that liquidated damages may have begun accruing as early as January 13, 2025. If we fail to make any payments for liquidated damages for seven days after the date payable, we are required to pay interest to the investor at a rate of 15% per annum accruing daily until the liquidated damages, plus all accrued interest, has been paid. In connection with our obligation to register the Registrable Securities held by investors in the November Offering, the December Offering, the January/February Offering and the March Offering, we filed a resale registration statement on March 4, 2025, to register for resale a total of 6,682,720 shares of Common Stock (or 133,654,397 shares of Common Stock prior to giving effect to the Second Reverse Split) including shares issuable upon exercise of outstanding warrants. All of the remaining Registrable Securities in those offerings were included in that registration statement. The registration statement is still pending and a large number of such Registrable Securities continue to be unregistered. Accordingly, liquidated damages under the registration rights agreements may still be accruing. Future sales of our Common Stock could cause the market price for our Common Stock to further decline. We cannot predict the effect, if any, that market sales of shares of our Common Stock or the availability of shares of our Common Stock, including upon exercise or conversion of any of our outstanding securities, for sale will have on the market price of our Common Stock prevailing from time to time. Sales of substantial amounts of shares of our Common Stock in the public market, or the perception that those sales will occur, could cause the market price of our Common Stock to decline or be depressed. As described elsewhere herein, we expect to issue additional securities, in the future, to raise capital to continue our operations. Additionally, we may issue our securities if we need to raise capital in connection with capital expenditure, working capital requirement or acquisition. The number of shares of our Common Stock issued in connection with a capital expenditure, working capital requirement or acquisition could constitute a material portion of our then-outstanding shares of Common Stock. Any perceived excess in the supply of our shares in the market could negatively impact our share price and any issuance of additional securities in connection with investments or acquisitions may result in additional dilution to you. The market price and trading volume of our